GLIOBLASTOMA MULTIFORME, ADULT
Clinical trials for GLIOBLASTOMA MULTIFORME, ADULT explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME, ADULT trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Sound waves plus drug may slow deadly brain tumor
Disease control Recruiting nowThis study tests whether adding focused ultrasound (NaviFUS) to the standard drug Avastin can help people with recurrent glioblastoma, an aggressive brain cancer. About 32 adults whose tumor has returned after prior treatment will be randomly assigned to receive Avastin alone or …
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated May 26, 2026 05:34 UTC
-
Brain cancer boost: new PET-Guided radiation aims to outsmart glioblastoma
Disease control Recruiting nowThis study tests a higher radiation dose for frail adults with glioblastoma who cannot have standard surgery. The extra dose is aimed at the most aggressive tumor areas, identified by a special FDOPA PET scan. The goal is to see if this approach can help people live longer. About…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated May 26, 2026 05:30 UTC
-
Could a new drug combo extend lives in aggressive brain cancer?
Disease control Recruiting nowThis study tests whether adding the drug ruxolitinib to standard treatment (radiation and temozolomide) helps people with newly diagnosed glioblastoma live longer. About 190 adults will be randomly assigned to receive either the standard treatment alone or standard treatment plus…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New radiation combo shows promise in tough brain cancer battle
Disease control Recruiting nowThis study tests a new drug called TLX101-Tx, which delivers targeted radiation directly to brain cancer cells, combined with standard chemotherapy (lomustine) in adults whose glioblastoma has returned after initial treatment. The goal is to see if the combination helps control t…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE3 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Disease control
Last updated May 20, 2026 11:58 UTC
-
Gene-Shielded chemo takes aim at deadly brain cancer
Disease control Recruiting nowThis study tests whether giving patients their own gene-modified stem cells can protect their bone marrow during high-dose chemotherapy for glioblastoma, an aggressive brain cancer. About 16 adults who recently had most of their tumor removed will receive the modified cells along…
Matched conditions: GLIOBLASTOMA MULTIFORME, ADULT
Phase: PHASE2 • Sponsor: Leland Metheny • Aim: Disease control
Last updated May 20, 2026 11:56 UTC